COMMUNIQUÉS West-GlobeNewswire

Windtree Announces Strategic Transaction to Drive Revenue Generation in Support of Ongoing Therapeutic Pipeline Development

01/05/2025 - 14:30

Initial transaction provides the right to buy the target asset which may provide consistent revenue to Windtree while it continues to develop its biotech pipeline drug candidates WARRINGTON, Pa., May 01, 2025 (GLOBE [...]

Extendicare Announces Agreement to Acquire Closing the Gap Healthcare Group

01/05/2025 - 14:30

MARKHAM, Ontario, May 01, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“ Extendicare ” or the “ Company ”) (TSX: EXE) announced today that its wholly owned home health care subsidiary, ParaMed Inc. (“ ParaMed ” or the “ [...]

Palisade Bio’s AI-Driven Approach to IBD Heterogeneity and Efficacy Selected for Presentation at the 3rd Annual Precision Medicine in Inflammatory Bowel Disease Summit

01/05/2025 - 14:30

Carlsbad, CA, May 01, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company focused on developing and advancing novel [...]

Adial Pharmaceuticals Expands Intellectual Property Portfolio with New U.S. Patent Granted for Genetic-Based Treatment of Alcohol and Opioid Use Disorders

01/05/2025 - 14:30

New patent covers a treatment method for a broad spectrum of alcohol-related disorders, including additional conditions associated with alcohol use GLEN ALLEN, Va., May 01, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals [...]

Wave Life Sciences First Quarter 2025 Financial Results Scheduled for May 8, 2025

01/05/2025 - 14:30

CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will [...]

Veru to Report Fiscal 2025 Second Quarter Financial Results on May 8

01/05/2025 - 14:30

MIAMI, May 01, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases [...]

Akari Therapeutics Appoints Mark F. Kubik as Head of Business Development - Oncology

01/05/2025 - 14:45

Global expertise in establishing and executing transformative transactions which have led to multiple approved therapeutic products Successful track record across oncology therapeutics including ADCs and antibody [...]

RoomSync Partners with Counslr to Launch the Fall Pass to Improve Community Well-being and Increase Revenue

01/05/2025 - 14:47

Student Residents Across the US to Have 24/7/365 Access to Text-based Mental Health Support to Mitigate Heightened Periods of Stress NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- Counslr, a leading digital mental health [...]

SPR Expands Access to the SPRINT® PNS System for Veterans with New Distribution Agreement with Veteran’s Health Medical Supply

01/05/2025 - 15:00

- National clinical review and contract offers an easier path to care for millions of Veterans - CLEVELAND, May 01, 2025 (GLOBE NEWSWIRE) -- SPR announced today that the SPRINT PNS System is now available on the [...]

BioCardia Announces First Patient in Phase 3 Randomized Controlled Double-Blind CardiAMP HF II Clinical Trial of the Company’s Lead Cell Therapy for Treatment of Heart Failure

01/05/2025 - 15:00

SUNNYVALE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [NASDAQ: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced [...]

Promex Industries Expands Best-in-Class Capabilities, Installing Laser Depaneling and Advanced SPI Systems on Manufacturing Line

01/05/2025 - 15:00

New Capabilities Support Higher-Density Assemblies, Flex Substrates, and Emerging Chiplet Architectures with Precision and Scale SANTA CLARA, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Promex Industries, Inc. , a Silicon [...]

Dupixent® (dupilumab) Data Presented at ATS Reinforce Impact of Targeting Key Type 2 Inflammation Drivers to Improve Outcomes for Chronic Respiratory Diseases

01/05/2025 - 15:00

24 abstracts, including 1 oral presentation and 4 late-breaking posters on Dupixent, to showcase new clinical and real-world analyses in chronic obstructive pulmonary disease (COPD) and asthma COPD data from the [...]

Resmed Acquires VirtuOx

01/05/2025 - 15:00

Acquisition supports Resmed’s growth in virtual care, expands access to diagnosis, and enhances the digital experience for patients and providers SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD [...]

Eleos Advances Comprehensive Behavioral Health Product Capabilities

01/05/2025 - 15:00

The new Eleos Documentation experience brings industry-leading augmented intelligence tools to more behavioral health use cases, 150+ languages, and rural or offline care settings Eleos dives deeper into Spring product [...]

Precision Neuroscience Adds Med-Tech Veterans To Accelerate Commercialization

01/05/2025 - 15:00

John Woock joins as Chief Business Officer; Konstantinos Alataris, PhD, appointed to Board of Directors NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision), a pioneering brain– [...]

HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program

01/05/2025 - 15:00

Southlake, TX, May 01, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company "), an artificial intelligence ("AI")-powered medical technology company focused on transforming [...]

Lyell Immunopharma Announces Oral Presentation of New Clinical Data from the Phase 1/2 Trial of LYL314 for the Treatment of Large B-cell Lymphoma at the International Conference on Malignant Lymphoma (ICML) 2025

01/05/2025 - 15:00

SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer, [...]

Senti Bio Releases Virtual Investor “What This Means” Segment

01/05/2025 - 15:15

Kanya Rajangam, MD, PhD, President, Head of R&D and Chief Medical Officer of Senti Bio discusses the positive data from lead program, SENTI-202, recently presented at the American Association for Cancer Research ( [...]

Intuitive Announces FDA Clearance of da Vinci Single Port for Transanal Local Excision/Resection

01/05/2025 - 15:15

SUNNYVALE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that the U.S. Food and [...]